NLRP3 and metabolic syndrome: From the presented literature, it is evident that dyslipidemia, a major risk factor for atherosclerosis, triggers inflammasome activation, particularly the NLRP3 inflammasome, through the recognition of lipid-related stimuli such as oxidized LDL and cholesterol crystals.